The pathogenetic role of IL-1β in severe epidermolysis bullosa simplex.
Verena
V
Wally
Thomas
T
Lettner
Patricia
P
Peking
Doris
D
Peckl-Schmid
Eva M
EM
Murauer
Stefan
S
Hainzl
Helmut
H
Hintner
Johann W
JW
Bauer
D000483:Alleles; D000880:Anthraquinones / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000906:Antibodies / Q000494:pharmacology; D002478:Cells, Cultured; D016110:Epidermolysis Bullosa Simplex / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000502:physiology*; D053547:Keratin-14 / Q000235:genetics / Q000378:metabolism; D015603:Keratinocytes / Q000378:metabolism / Q000473:pathology; D020935:MAP Kinase Signaling System / Q000502:physiology*; D009154:Mutation / Q000235:genetics; D012720:Severity of Illness Index; D015398:Signal Transduction / Q000502:physiology*
D000880:Anthraquinones; D000893:Anti-Inflammatory Agents; D000906:Antibodies; D053583:Interleukin-1beta; D053547:Keratin-14; C025292:diacerein